10.34
+0.37(+3.71%)
Currency In USD
| Previous Close | 9.97 |
| Open | 10.13 |
| Day High | 10.49 |
| Day Low | 10.07 |
| 52-Week High | 11.11 |
| 52-Week Low | 5.06 |
| Volume | 5.52M |
| Average Volume | 4.33M |
| Market Cap | 2.16B |
| PE | -39.77 |
| EPS | -0.26 |
| Moving Average 50 Days | 7.91 |
| Moving Average 200 Days | 7.83 |
| Change | 0.37 |
If you invested $1000 in BioCryst Pharmaceuticals, Inc. (BCRX) 10 years ago, it would be worth $1,003.88 as of May 13, 2025 at a share price of $10.34. Whereas If you bought $1000 worth of BioCryst Pharmaceuticals, Inc. (BCRX) shares 5 years ago, it would be worth $2,110.2 as of May 13, 2025 at a share price of $10.34.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
BioCryst Appoints Steve Frank to Board of Directors
GlobeNewswire Inc.
May 01, 2025 11:00 AM GMT
RESEARCH TRIANGLE PARK, N.C., May 01, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company has appointed healthcare investment banking leader Steve Frank to its board of directors. Mr. Frank serves
BioCryst to Report First Quarter 2025 Financial Results on May 5
GlobeNewswire Inc.
Apr 21, 2025 11:00 AM GMT
RESEARCH TRIANGLE PARK, N.C., April 21, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will report its first quarter 2025 financial results on Monday, May 5, 2025. BioCryst management will ho
BioCryst to Present at Upcoming Investor Conference
GlobeNewswire Inc.
Apr 02, 2025 8:01 PM GMT
RESEARCH TRIANGLE PARK, N.C., April 02, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company plans to present at the 24th Annual Needham Virtual Healthcare Conference on Wednesday, April 9, 2025, a